Teladoc Health (NYSE:TDOC) Shares Down 3.4% – What’s Next?

Teladoc Health, Inc. (NYSE:TDOC)’s stock price fell 3.4% during mid-day trading on Friday . The company traded as low as $9.18 and last traded at $9.20. 890,929 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 1,878,147 shares. The stock had previously closed at $9.52.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of research analyst reports. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research note on Wednesday, October 9th. The Goldman Sachs Group began coverage on shares of Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 price target on the stock. Evercore ISI increased their target price on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Jefferies Financial Group lifted their target price on Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a report on Tuesday, September 17th. Finally, TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, Teladoc Health presently has an average rating of “Hold” and an average price target of $12.24.

Teladoc Health Price Performance

The stock has a market cap of $1.63 billion, a price-to-earnings ratio of -1.64 and a beta of 0.97. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock’s 50 day simple moving average is $9.87 and its two-hundred day simple moving average is $9.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. On average, analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Institutional investors have recently added to or reduced their stakes in the stock. Signaturefd LLC raised its position in Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after buying an additional 1,715 shares during the last quarter. International Assets Investment Management LLC bought a new stake in Teladoc Health during the 2nd quarter worth about $29,000. Versant Capital Management Inc boosted its stake in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after acquiring an additional 1,854 shares in the last quarter. Finally, Doheny Asset Management CA bought a new stake in Teladoc Health during the second quarter worth about $46,000. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.